Red Sox Nation Puts Faith in New Baseball Operations Leader, Craig Breslow

The Boston Red Sox find themselves in a unique situation at the midway point of the MLB season. After a disappointing 2023 season, there was a lot of skepticism surrounding the team's prospects this year. The Red Sox have a chance to make the postseason despite these doubts. Consequently, it is unclear whether the Red Sox are buyers or sellers at the trade deadline.

The team's chief baseball officer, Craig Breslow, has his work cut out for him. With a plethora of talented teams in their division, the Red Sox will need to make careful and calculated decisions to have a successful season.

Fortunately, Breslow has past experience in similar situations. As the first Red Sox head of baseball operations with major league playing experience since 1978, Breslow hopes to leverage his experience to the club's advantage.

Furthermore, the team's outfield has been a pleasant surprise this year. With top prospects failing to live up to expectations, the current roster has stepped up to the plate. Tyler O'Neill has been a welcome addition to the left field, and Wilyer Abreu and Jarren Duran have excelled in their expanded roles. With the defensive improvements, it seems the team is buying despite their uncertain standing.

Additionally, the team's pitching has been remarkable. Despite a slow start, the staff has found their form and has been one of the best in the league. Andrew Bailey, the team's pitching coach, deserves much of the credit for the turnaround. Breslow has been involved in daily conversations with Bailey and manager Alex Cora.

Although the Red Sox have a lot of work ahead of them, there is reason to be positive about the team's future. They have a capable leader in Breslow, a standout defensive group, and a powerful pitching staff.

Read more

Prospective observational study of peripheral intravenous cannula utilisation and frequency of intravenous fluid delivery in the emergency department: convenience or necessity?

Introduction Over one billion peripheral intravenous cannulas (PIVCs) are inserted worldwide each year. Insertion of PIVCs is associated with pain, phlebitis, occlusion, and medication extravasation as well as the risk of catheter-associated infection, with an associated cost to departmental resources. Previous studies have not assessed if intravenous (IV) fluid delivery